TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19530940

Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 17707753

Group type: EXPERIMENTAL
Intervention: Adjuvanted vaccine (3.8 microg)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Adjuvanted vaccines (all doses)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Non-adjuvanted vaccines (all doses)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: All vaccine formulations
Number of subjects: 400
Study: 15533143

Group type: EXPERIMENTAL
Intervention: ENT review at 1 week and 1 month (Group A)
Number of subjects: 66

Group type: COMPARATOR
Intervention: ENT review at 1 month only (Group B)
Number of subjects: 66
Study: 11589769

Group type: EXPERIMENTAL
Intervention: Cyclosporine monotherapy (CsA)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Tacrolimus monotherapy
Number of subjects: 37

Group type: COMPARATOR
Intervention: Triple therapy (CAP)
Number of subjects: 37
Study: 9458147

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (group I) with cold blood cardioplegia
Number of subjects: 14

Group type: COMPARATOR
Intervention: Cold intermittent blood cardioplegia (group II)
Number of subjects: 14
Study: 8201130

Group type: EXPERIMENTAL
Intervention: Bright light for 1 h daily for 2 weeks
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 15-min exposure to light daily
Number of subjects: 26
Study: 3295209

Group type: EXPERIMENTAL
Intervention: Amitriptyline (AMI)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Imipramine (IMI)
Number of subjects: 95
Study: 29357012

Group type: EXPERIMENTAL
Intervention: Polyglycolic acid (PGA) sheets and fibrin glue
Number of subjects: 84

Group type: COMPARATOR
Intervention: ESD only (Control)
Number of subjects: 84
Study: 26946958

Group type: EXPERIMENTAL
Intervention: 50 Hz-tACS
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 300 Hz-tACS
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 10 Hz-tACS
Number of subjects: 25

Group type: COMPARATOR
Intervention: sham-tACS
Number of subjects: 25
Study: 24799686

Group type: EXPERIMENTAL
Intervention: Intervention group (trained in meditation, breathing techniques, and cold exposure)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not trained)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 23530729

Group type: EXPERIMENTAL
Intervention: Foley catheter
Number of subjects: 819

Group type: COMPARATOR
Intervention: Prostaglandin E₂ gel
Number of subjects: 819
Study: 20419525

Group type: EXPERIMENTAL
Intervention: Olanzapine for adjunctive treatment of anorexia nervosa
Number of subjects: 92
Study: 19902046

Group type: EXPERIMENTAL
Intervention: Scaling and root planing only (Group A)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Scaling and root planing followed by systemic doxycycline (Group B)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No treatment (Control Group C)
Number of subjects: 45
Study: 16909188

Group type: EXPERIMENTAL
Intervention: Oral trimethoprim (TMP) 5 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral trimethoprim (TMP) 10 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral trimethoprim (TMP) 20 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second dose of oral TMP 5 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second dose of oral TMP 10 mg/kg
Number of subjects: 0
Study: 15072506

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg/day (n = 15)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (n = 14)
Number of subjects: 29
Study: 11035692

Group type: EXPERIMENTAL
Intervention: Therapeutic thoracentesis
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tube thoracostomy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fibrinolytics
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic surgery (VATS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Surgery (including thoracotomy with or without decortication and rib resection)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No drainage performed
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no drainage)
Number of subjects: 20
Study: 8818070

Group type: EXPERIMENTAL
Intervention: Intervention group with a 2.4% reduction in total fat intake
Number of subjects: 1182

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1182

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 1182
Study: 1568369

Group type: EXPERIMENTAL
Intervention: Metadoxine (500 mg twice a day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (vitamins)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Metadoxine
Number of subjects: 72
Study: 3904379

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 127

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 127
Study: 31064374

Group type: EXPERIMENTAL
Intervention: Watching a short film about a negative event relating to depression (experimental group)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Watching a short film about a negative event without relation to depression (control group 1)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Watching a neutral event relating to depression (control group 2)
Number of subjects: 180
Study: 30300099

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) - 8-10 sessions of red and infrared lasers over the flexor tendon repaired area
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (no LLLT)
Number of subjects: 97
Study: 26871651

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 283

Group type: COMPARATOR
Intervention: Prolonged conservative care
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: MRI assessment of nerve root compression
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: MRI assessment of extrusion vs protrusion of disc herniation
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: MRI findings
Number of subjects: 283
Study: 23744513

Group type: EXPERIMENTAL
Intervention: DHEA (50 mg/day) + COC (20 µg ethinyl estradiol/0.1 mg levonorgestrel)
Number of subjects: 80
Study: 22413782

Group type: EXPERIMENTAL
Intervention: Intervention group (20 schools)
Number of subjects: 2156

Group type: COMPARATOR
Intervention: Control group (20 schools)
Number of subjects: 2156
Study: 20134374

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous sufentanil
Number of subjects: 50
Study: 17432701

Group type: EXPERIMENTAL
Intervention: Arteriojugular venous differences of lactate (AVDL)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Cerebral lactate concentration (gold standard)
Number of subjects: 45
Study: 16238653

Group type: EXPERIMENTAL
Intervention: Magic trick distraction (Magic+)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Tell-show-do (TSD) (Magic-)
Number of subjects: 70
Study: 11870439

Group type: COMPARATOR
Intervention: Storage-phosphor technology (SPT) at standard dose (speed class S400, n=25)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Standard-dose FDT (S400, n=25)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Low-dose FDT (S800, n=25)
Number of subjects: 75
Study: 9535527

Group type: EXPERIMENTAL
Intervention: Weak SCI subjects
Number of subjects: 28

Group type: COMPARATOR
Intervention: Nonweak SCI subjects
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 28
Study: 7624386

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sulpiride
Number of subjects: 19
Study: 2695384

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation
Number of subjects: 8
Study: 330825

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 18
Study: 30699039

Group type: EXPERIMENTAL
Intervention: LARS procedure
Number of subjects: 47

Group type: COMPARATOR
Intervention: MBG procedure
Number of subjects: 47
Study: 26318373

Group type: EXPERIMENTAL
Intervention: Jejunostomy feeding tube (JFT)
Number of subjects: 15
Study: 26161664

Group type: EXPERIMENTAL
Intervention: Bilateral tDCS with right prefrontal anodal and left prefrontal cathodal montage
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Bilateral tDCS with left prefrontal anodal and right prefrontal cathodal montage
Number of subjects: 69

Group type: COMPARATOR
Intervention: Sham stimulation (control group)
Number of subjects: 69
Study: 23121460

Group type: EXPERIMENTAL
Intervention: SRP + boric acid irrigation (0.75%)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: SRP + chlorhexidine irrigation (CHX)
Number of subjects: 45

Group type: COMPARATOR
Intervention: SRP + saline irrigation (C)
Number of subjects: 45
Study: 20673253

Group type: EXPERIMENTAL
Intervention: Heel cup
Number of subjects: 51

Group type: COMPARATOR
Intervention: Heel wedge
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Heel cup (preference)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Insole use at 1-year follow-up
Number of subjects: 51
Study: 19736502

Group type: EXPERIMENTAL
Intervention: Circumoral muscle exercises
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 16434453

Group type: EXPERIMENTAL
Intervention: 0.3 mg rhTSH
Number of subjects: 10

Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 10
Study: 15487684

Group type: EXPERIMENTAL
Intervention: Residential indoor PM2.5
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Residential outdoor PM2.5
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Workplace indoor PM2.5
Number of subjects: 178

Group type: COMPARATOR
Intervention: Outdoor fixed-site monitoring
Number of subjects: 178
Study: 10682941

Group type: EXPERIMENTAL
Intervention: Aerobic walking
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Weight training
Number of subjects: 103

Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 103
Study: 9480565

Group type: EXPERIMENTAL
Intervention: Valproate (300, 600, or 1200 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Naloxone (infusion 1.6 mg/h for 6 h)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Valproate and Naloxone
Number of subjects: 150
Study: 7909705

Group type: EXPERIMENTAL
Intervention: Felodipine (5 mg) plus Metoprolol (50 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Nifedipine (20 mg) plus Atenolol (50 mg)
Number of subjects: 6
Study: 3781700

Group type: EXPERIMENTAL
Intervention: Ambroxol (1.5‐2.0 mg/kg body weight orally)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 2826066

Group type: EXPERIMENTAL
Intervention: Nisoldipine 20 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nisoldipine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 12
Study: 31845203

Group type: EXPERIMENTAL
Intervention: Initial clinical assessment including sex, symptom reporting, and physiological predominant symptom cluster
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Higher Positive Symptom Total at initial assessment
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Physiological predominant symptom cluster
Number of subjects: 568
Study: 31297674

Group type: EXPERIMENTAL
Intervention: Magtrace (magnetic tracer)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Standard technique (radioisotope and blue dye)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 146
Study: 28629344

Group type: EXPERIMENTAL
Intervention: ONO-5334 100 mg QD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ONO-5334 300 mg QD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ONO-5334 50 mg BID
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of ONO-5334 50 mg BID vs. 100 mg QD
Number of subjects: 0
Study: 25443461

Group type: EXPERIMENTAL
Intervention: Bevacizumab (BVZ)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Mitomycin C (MMC)
Number of subjects: 45
Study: 23647406

Group type: EXPERIMENTAL
Intervention: Yoga Nidra (35-40 minutes/day, five times/week for 6 months)
Number of subjects: 150
Study: 21515892

Group type: EXPERIMENTAL
Intervention: Modular Socket System (MSS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: standard laminated socket (PC)
Number of subjects: 20
Study: 17999174

Group type: EXPERIMENTAL
Intervention: Multivitamin
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: B-complex vitamin
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Placebo vitamin
Number of subjects: 114

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 114
Study: 16776894

Group type: EXPERIMENTAL
Intervention: Special intervention (individual counseling visit, twelve group sessions, three postcard messages, twelve monthly telephone calls)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Minimal intervention (control group)
Number of subjects: 201
Study: 12830438

Group type: EXPERIMENTAL
Intervention: Short daily hemodialysis
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Long nocturnal hemodialysis
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (conventional hemodialysis)
Number of subjects: 23
Study: 11081529

Group type: EXPERIMENTAL
Intervention: Post-treatment isoniazid prophylaxis
Number of subjects: 233

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: HIV-1-positive individuals
Number of subjects: 233

Group type: COMPARATOR
Intervention: HIV-1-negative individuals
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: HIV-1-positive individuals with a history of HIV-1-related symptoms
Number of subjects: 233
Study: 9172054

Group type: EXPERIMENTAL
Intervention: Plasma alkaline phosphatase (AP) in the highest quartile at 26 weeks
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Increase in plasma alkaline phosphatase (AP) from 19 to 26 weeks (highest quartile)
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Mean birthweight (BWT) for highest quartile of increase in AP
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Mean gestational age (GA) for highest quartile of increase in AP
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: High AP at 26 weeks
Number of subjects: 580
Study: 1588829

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg/d and 40 mg/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fenofibrate (400 mg/d)
Number of subjects: 0
Study: 3014473

Group type: EXPERIMENTAL
Intervention: Oka-strain live varicella vaccine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Zinc acetate as an immunostimulant
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 29224964

Group type: EXPERIMENTAL
Intervention: Two doses of MMRV vaccine
Number of subjects: 5289

Group type: EXPERIMENTAL
Intervention: One dose of combined MMR and one dose of monovalent varicella vaccine (MMR+V)
Number of subjects: 5289

Group type: COMPARATOR
Intervention: Two doses of MMR vaccine (control)
Number of subjects: 5289

Group type: EXPERIMENTAL
Intervention: Herpes zoster cases
Number of subjects: 5289
Study: 27061991

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training three times a week for six weeks and counselling
Number of subjects: 40

Group type: COMPARATOR
Intervention: Counselling only
Number of subjects: 40
Study: 25439688

Group type: EXPERIMENTAL
Intervention: Axillary lymph node dissection
Number of subjects: 4806

Group type: COMPARATOR
Intervention: Axillary radiotherapy
Number of subjects: 4806
Study: 22631672

Group type: EXPERIMENTAL
Intervention: Endostar combined with chemoradiotherapy (CRT+E group)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Chemoradiotherapy alone (CRT group)
Number of subjects: 52
Study: 20808194

Group type: EXPERIMENTAL
Intervention: Silver yoga (SY) exercise program, 3 times per week, 70 minutes per session, for 24 weeks
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 69
Study: 18923351

Group type: EXPERIMENTAL
Intervention: Transanal endoscopic microsurgery (TEM)
Number of subjects: 0
Study: 16877146

Group type: EXPERIMENTAL
Intervention: Epoetin alfa 40,000 U at preoperative days 14 and 7
Number of subjects: 50

Group type: COMPARATOR
Intervention: Epoetin alfa
Number of subjects: 50
Study: 12449158

Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 10738354

Group type: EXPERIMENTAL
Intervention: Stenting (2 VD, high costs)
Number of subjects: 1205

Group type: EXPERIMENTAL
Intervention: Stenting (3 VD, high costs)
Number of subjects: 1205

Group type: EXPERIMENTAL
Intervention: Stenting (2 VD, low costs)
Number of subjects: 1205

Group type: EXPERIMENTAL
Intervention: Stenting (3 VD, low costs)
Number of subjects: 1205

Group type: COMPARATOR
Intervention: CABG (high costs)
Number of subjects: 1205

Group type: COMPARATOR
Intervention: CABG (low costs)
Number of subjects: 1205
Study: 8787472

Group type: EXPERIMENTAL
Intervention: Cold crystalloid cardioplegia
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Cold blood cardioplegia
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Warm blood cardioplegia
Number of subjects: 47
Study: 2108474

Group type: EXPERIMENTAL
Intervention: High dose pion irradiation (total doses from 2720-3420 cGy, fraction sizes from 170 to 205 cGy, treatment times from 4 to 5 weeks)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Accelerated treatment with 3280 cGy in 14-22 days
Number of subjects: 52

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 52
Study: 6107154

Group type: EXPERIMENTAL
Intervention: Cimetidine (1 g daily)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Ranitidine (200 mg daily)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 38
Study: 29542390

Group type: EXPERIMENTAL
Intervention: Omega-3 (300 mg daily, 180 mg EPA and 120 mg DHA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Vitamin E (200 IU daily)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Vitamin E + Omega-3
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 27440110

Group type: EXPERIMENTAL
Intervention: liraglutide 1.8 mg once daily
Number of subjects: 90

Group type: COMPARATOR
Intervention: sitagliptin 100 mg once daily
Number of subjects: 90
Study: 23764766

Group type: EXPERIMENTAL
Intervention: Surgical reduction (group 1, n=45)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Fusion in situ (group 2, n=43)
Number of subjects: 88
Study: 22568428

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with 5‐fluorouracil
Number of subjects: 199

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with cataract surgery (Phaco/IOL)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with cataract surgery
Number of subjects: 199
Study: 21400790

Group type: EXPERIMENTAL
Intervention: Calcium antagonists and hydroxyethyl starch solution (130/0.4)
Number of subjects: 0
Study: 17626211

Group type: EXPERIMENTAL
Intervention: Instrumental shaping procedure with monetary reward
Number of subjects: 22
Study: 16215340

Group type: EXPERIMENTAL
Intervention: 24% sucrose plus pacifier
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Sterile water plus pacifier
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard care (positioning and swaddling)
Number of subjects: 66
Study: 12054319

Group type: EXPERIMENTAL
Intervention: Telephone-delivered coping improvement-group intervention
Number of subjects: 201
Study: 9745188

Group type: EXPERIMENTAL
Intervention: Interferon therapy
Number of subjects: 13
Study: 7992066

Group type: EXPERIMENTAL
Intervention: Radiochemotherapy plus carboplatin (60 to 70 mg/m2/d, days 1-5 and 29-33) with radiotherapy (5 x 2 Gy/wk to a dose of 50 Gy, continued to 70-74 Gy for inoperable patients)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Hyperfractionated accelerated radiotherapy (2 x 1.6 Gy/d 5 days per week; total dose, 64 to 67.2 Gy) plus simultaneous intravenous carboplatin (60 mg/m2, days 1-5 and 29-33)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Conventional radiotherapy plus carboplatin
Number of subjects: 178

Group type: COMPARATOR
Intervention: Hyperfractionated accelerated irradiation plus carboplatin
Number of subjects: 178
Study: 2656068

Group type: EXPERIMENTAL
Intervention: CPAP 12.5 cm H2O
Number of subjects: 10
Study: 31928248

Group type: EXPERIMENTAL
Intervention: LOG model intervention implemented in 19 schools
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: LOG model intervention
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group (16 schools)
Number of subjects: 157
Study: 29948025

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 608

Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 608
Study: 28821284

Group type: EXPERIMENTAL
Intervention: 12-week combined aerobic and resistance exercise program supervised by a physiotherapist, plus daily physical activity of at least 30 minutes
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care group maintaining habitual physical activity pattern
Number of subjects: 150
Study: 25778445

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23232755

Group type: EXPERIMENTAL
Intervention: Drug therapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Cognitive behaviour therapy
Number of subjects: 29
Study: 22011360

Group type: EXPERIMENTAL
Intervention: Nintendo Wii Fit
Number of subjects: 21

Group type: COMPARATOR
Intervention: Traditional therapy
Number of subjects: 21
Study: 19433655

Group type: EXPERIMENTAL
Intervention: Pramipexole (n = 151)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Levodopa (n = 150)
Number of subjects: 301
Study: 16988496

Group type: EXPERIMENTAL
Intervention: Vegan diet
Number of subjects: 118

Group type: COMPARATOR
Intervention: Omnivore diet
Number of subjects: 118

Group type: COMPARATOR
Intervention: Vegetarian diet
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 118
Study: 15269867

Group type: EXPERIMENTAL
Intervention: tinidazole‐dexamethasone‐iodoform paste
Number of subjects: 520

Group type: COMPARATOR
Intervention: formocresol
Number of subjects: 520